Ceftobiprole Medocaril
4 interactions 1 explained in plain English
Medically reviewed by
Dr. Brian Staiger, PharmD, BCPS
· Updated Jul 4, 2026
· Editorial policy
· Data sources
Sources: FDA prescribing information (Structured Product Labeling), the published literature cited in each entry, DDInter 2.0 (a major open-access drug-interaction database), and legacy DrugBank interaction data distributed by the NIH's RxNav service (decommissioned in 2024) — analyzed and reviewed by our pharmacist team. How we build this library →
Major
Ceftobiprole Medocaril Simvastatin Flolipid Explained Increased OATP1B1 substrate exposure and an increased OATP1B3 substrate exposure Details Ceftobiprole Medocaril Atogepant Qulipta Increased OATP1B1 substrate exposure and an increased OATP1B3 substrate exposure Details Ceftobiprole Medocaril Atorvastatin Atorvaliq Increased OATP1B1 substrate exposure and an increased OATP1B3 substrate exposure Details Ceftobiprole Medocaril Furosemide Injection Disal Increased risk of cephalosporin-induced nephrotoxicity DetailsNo interactions on this page match that filter — try the next page or clear the filter.
Check another drug
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacistEducational information only, not medical advice. Always confirm interactions with your pharmacist
or prescriber before making any change to your medications.